Cargando…
2770. Investigating the Impact of Non-CTX-M Producing ESBL-E Bloodstream Infections on Patient Outcomes
BACKGROUND: Studies investigating optimal treatment and patient outcomes for extended-spectrum β-lactamase-producing Enterobacterales (ESBL-E) generally do not distinguish between ESBL genes in bloodstream infections (BSI). To address a key knowledge gap, we compare the clinical outcomes of patients...
Autores principales: | Hareza, Dariusz A, Simner, Patricia J, Fiawoo, Suiyini, Lee, Jae Hyoung, Bergman, Yehudit, Jacobs, Emily B, Cosgrove, Sara E, Tamma, Pranita |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10679080/ http://dx.doi.org/10.1093/ofid/ofad500.2381 |
Ejemplares similares
-
The Frequency of Extended-Spectrum β-Lactamase Genes Harbored by Enterobacterales Isolates at High Risk for Clinically Significant Chromosomal ampC Expression
por: Hareza, Dariusz, et al.
Publicado: (2023) -
2487. Which Extended-Spectrum β-Lactamase-Producing Enterobacterales Colonize the Gastrointestinal Tract of High-Risk Patients?
por: Stambaugh, Haley, et al.
Publicado: (2023) -
203. Evaluating the Impact of Extended-Infusion Beta-Lactam Therapy on Clinical Outcomes and the Subsequent Emergence of Resistance in Adults with Gram-Negative Bloodstream Infections
por: Karaba, Sara M, et al.
Publicado: (2023) -
Epidemiology of Gram-Negative Bloodstream Infections in the United States: Results From a Cohort of 24 Hospitals
por: Ince, Dilek, et al.
Publicado: (2023) -
An NDM-Producing Escherichia coli Clinical Isolate Exhibiting Resistance to Cefiderocol and the Combination of Ceftazidime-Avibactam and Aztreonam: Another Step Toward Pan-β-Lactam Resistance
por: Simner, Patricia J, et al.
Publicado: (2023)